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Gain-of-function experiments have demonstrated
the potential of Notch signals to expand primitive
hematopoietic progenitors, but whether Notch phys-
iologically regulates hematopoietic stem cell (HSC)
homeostasis in vivo is unclear. To answer this ques-
tion, we evaluated the effect of global deficiencies
of canonical Notch signaling in rigorous HSC assays.
Hematopoietic progenitors expressing dominant-
negative Mastermind-like1 (DNMAML), a potent in-
hibitor of Notch-mediated transcriptional activation,
achieved stable long-term reconstitution of irradi-
ated hosts and showed a normal frequency of pro-
genitor fractions enriched for long-term HSCs. Simi-
lar results were observed with cells lacking CSL/
RBPJ, a DNA-binding factor that is required for ca-
nonical Notch signaling. Notch-deprived progenitors
provided normal long-term reconstitution after sec-
ondary competitive transplantation. Furthermore,
Notch target genes were expressed at low levels in
primitive hematopoietic progenitors. Taken together,
these results rule out an essential physiological
role for cell-autonomous canonical Notch signals in
HSC maintenance.
INTRODUCTION
Notch is a highly conserved signaling pathway that regulates
cell-fate decisions and tissue homeostasis in multiple contexts
(Artavanis-Tsakonas et al., 1999). Mammals have four Notch
genes (Notch1–4), which encode cell surface receptors with dis-
tinct, but overlapping, patterns of expression. Canonical Notch
signaling is initiated by ligands of the Jagged or Delta-like fami-
lies. Ligand binding initiates several successive proteolytic
356 Cell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc.cleavages, which culminate in intramembrane proteolysis by
a gamma-secretase complex and release of the intracellular
domain of Notch (ICN) (De Strooper et al., 1999). ICN then exerts
its activity in the nucleus as part of a large transcriptional activa-
tion complex (Jeffries et al., 2002). Essential components of this
complex include ICN, the transcription factor CSL/RBPJ, and
transcriptional coactivators of the Mastermind-like (MAML) fam-
ily (MAML1–3) (Jarriault et al., 1995; Tamura et al., 1995; Wu
et al., 2000, 2002). Upon Notch activation, ICN binds to CSL/
RBPJ and creates a dual-binding interface for MAML, forming
a ternary complex that is essential for transcriptional activation
of Notch target genes (Nam et al., 2006; Wilson and Kovall,
2006).
Notch regulates progenitor self-renewal and differentiation in
various organs, such as in neural tissue, muscle, skin, and gut
(Chiba, 2006). In the hematopoietic system, Notch is essential
for the emergence of definitive hematopoietic stem cells (HSCs)
during fetal life (Kumano et al., 2003; Hadland et al., 2004). Notch
subsequently plays a critical role in splenic marginal zone B
(MZB) cell development and at several stages of T cell develop-
ment (reviewed in Radtke et al., 2004; Maillard et al., 2005; Visan
et al., 2006). In addition, it has been widely hypothesized that
Notch ligands are a critical component of HSC niches and pro-
mote HSC maintenance by activating Notch receptors expressed
in HSCs. Gain-of-function experiments suggest that Notch sig-
naling increases self-renewal and decreases differentiation of
hematopoietic progenitors. In these experiments, elevated levels
of Notch signaling were achieved through exposure of progeni-
tors to Notch ligands in vitro (Varnum-Finney et al., 1998, 2003;
Karanu et al., 2001; Suzuki et al., 2006), overexpression of consti-
tutively activeNotch alleles (Carlesso et al., 1999; Varnum-Finney
et al., 2000; Stier et al., 2002; Burns et al., 2005), overexpression
of the Notch downstream target Hes1 (Kunisato et al., 2003;
Yu et al., 2006), or activation of Jagged1 expression through
osteoblast stimulation (Calvi et al., 2003). Thus, multiple reports
show that experimental manipulations that increase Notch
signaling enhance the self-renewal of primitive hematopoietic
progenitors.
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Notch and Adult Hematopoietic Stem CellsFigure 1. Stable Engraftment of DNMAML-
Transduced Progenitors
(A) Lethally irradiated mice were reconstituted with
5-FU-treated BM cells after transduction with the
GFP-expressing retrovirus MigR1 or with a retro-
virus expressing the GFP-tagged Notch inhibitor
DNMAML. Percentage of GFP+ cells among
Gr1+CD11b+ myeloid cells in the peripheral blood
4 and 20 weeks after transplantation. The percent-
ages are means ± SDs (n = 4 in each group). The
experiment is representative of ten similar experi-
ments.
(B) Relative percentage of GFP+ myeloid cells at
various time points after bone marrow transplanta-
tion (BMT), with the percentage observed at week
4 normalized to 1. The data represent the normal-
ized means ± SDs (n = 4). White triangles, MigR1;
black squares, DNMAML.
(C) Contribution of CD45.2+ cells to blood
Gr1+CD11b+ myeloid cells after competitive trans-
plantation of CD45.1+ BM and poly(I:C)-induced
Mx-Cre– ROSADNMAML/+ BM (white triangles) or
Mx-Cre+ ROSADNMAML/+ BM (black triangles) (1:1
ratio). Data shown are the means ± SDs for nine
control and eight DNMAML recipients.In contrast, whether Notch signaling has an obligate role in
HSC self-renewal is controversial. Duncan et al. showed that
a Notch reporter transgene was activated in primitive bone mar-
row (BM) progenitors, and blockade of Notch signaling with
gamma-secretase inhibitors in vitro or with a dominant-negative
form of the Xenopus CSL/RBPJ homolog in vitro and in vivo in-
creased differentiation and decreased progenitor self-renewal
(Duncan et al., 2005). At first glance, these results appear to
disagree with previous work in which genetic inactivation of
the Rbpj gene (encoding CSL/RBPJ) caused a failure of T and
MZB cell development, but no other obvious hematopoietic phe-
notype (Han et al., 2002; Tanigaki et al., 2002). However, strin-
gent assays of HSC function were not performed with CSL/
RBPJ-deficient progenitors. In addition, inactivation of Notch1
and combined inactivation of Notch1 and Jagged1 have not
revealed defects in HSC function (Radtke et al., 1999; Mancini
et al., 2005); however, these studies did not rule out redundant
effects from other Notch receptors or ligands. Hence, whether
Notch signaling is essential for HSC maintenance under physio-
logical conditions remains unknown.
To resolve this issue, we inhibited all canonical Notch signals
in adult HSCs by either expressing a dominant-negative Master-
mind-like1 construct fused to GFP (DNMAML) (Weng et al.,
2003; Maillard et al., 2004, 2006a, 2006b; Sambandam et al.,
2005; Tu et al., 2005) or by conditional deletion of Rbpj. In strin-
gent stem cell assays, DNMAML-expressing cells and CSL/
RBPJ-deficient cells failed to show any defect when allowed to
compete with normal HSCs in vivo. We also noted that, although
HSCs respond to Notch ligands ex vivo, the Notch signaling toneof normal HSCs appears to be low in the BM microenvironment.
Our results argue strongly against an obligate physiologic role for
Notch signaling in adult BM HSCs.
RESULTS
Stable Engraftment of DNMAML-Transduced Cells
A comprehensive assessment of the physiological effects of
Notch in vivo requires inhibition of signaling from all four Notch
receptors. To this end, we developed a dominant-negative Mas-
termind-like1 construct (DNMAML), encoding the N-terminal
Notch-binding domain of MAML1 fused to GFP (Weng et al.,
2003; Maillard et al., 2004). The DNMAML-GFP fusion protein in-
terferes with the Notch transcriptional activation complex, lead-
ing to potent inhibition of Notch1–4 signaling in vitro and in vivo,
while allowing us to track single cells deprived of Notch signaling
(Weng et al., 2003; Maillard et al., 2004, 2006a, 2006b; Samban-
dam et al., 2005; Tu et al., 2005).
We first transduced adult HSCs with a GFP-expressing retrovi-
rus (MigR1) or a retrovirus encoding DNMAML-GFP (DNMAML),
and these cells were used to reconstitute lethally irradiated mice
with a mixed population of transduced tester and untransduced
competitor progenitors. The degree of chimerism achieved after
transplantation of MigR1 and DNMAML-transduced progenitors
was high, both at early (4 weeks) and late time points (20 weeks)
(Figure 1A). The percentage of GFP+ myeloid cells remained
stable over time and was not significantly different between
MigR1 and DNMAML cohorts (Figure 1B). As shown previously,
DNMAML expression resulted in profound inhibition of T andCell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc. 357
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Notch2, respectively (Maillard et al., 2004; Sambandam et al.,
2005).
To exclude any confounding effect of retroviral transduction,
we generatedROSADNMAML/+mice in which DNMAML is knocked
into theROSA26 locus downstream of a floxed stop cassette (Tu
et al., 2005; Maillard et al., 2006b). We bred these mice toMx-Cre
transgenic mice and induced Cre expression with poly(I:C). This
routinely led to DNMAML expression in >98% of BM progenitors
(Figure S1 available online). We mixed BM cells from poly(I:C)-in-
duced Mx-Cre+3 ROSADNMAML/+ mice or from control poly(I:C)-
treated mice with a fixed dose of CD45.1+ competitor cells and
used these mixtures to reconstitute lethally irradiated recipients
(Figure 1C). We observed similar levels of stable long-term chime-
rism in animals with Notch-replete and Notch-deficient progeni-
tors. Importantly, as with retroviral transduction, DNMAML ex-
pression from the ROSA26 locus led to efficient Notch inhibition
in vivo, as shown by a complete blockade of T and MZB cell de-
velopment (Figure S2). Overall, these data indicate that wild-type
progenitors do not have a competitive advantage over DNMAML-
expressing cells in primary transplantation experiments.
Normal Frequency of DNMAML-Expressing
Hematopoietic Progenitors
Long-term hematopoietic stem cells (LT-HSCs) are found in a
population characterized by no or low-level expression of line-
age markers, high Sca-1, and high c-Kit expression (Lin–/loSca-
1hic-Kithi, LSK cells) (Kondo et al., 2003). Defects in HSC homeo-
stasis often result in an abnormal LSK frequency (Kondo et al.,
2003). Therefore, we assessed the frequency of LSK progenitors
in GFP+ MigR1 or DNMAML-transduced BM cells late after
transplantation. The LSK frequency was similar among MigR1
and DNMAML-transduced BM cell populations (Figure 2A). Fur-
thermore, there was no significant difference in LSK frequency
between untransduced (GFP–) and transduced (GFP+) BM in
cohorts of MigR1 and DNMAML mice (Figure 2B). Similarly,
DNMAML did not alter the frequency of BM LSK progenitors in
poly(I:C)-induced Mx-Cre+ 3 ROSADNMAML/+ mice (Figure 2C).
Normal Frequency of DNMAML-Expressing
LT-HSC Progenitors
The LSK population is heterogeneous and contains both LT-
HSCs and progenitors with multilineage potential but limited
self-renewal capacity (Morrison and Weissman, 1994; Kondo
et al., 2003). Therefore, we assessed the effect of DNMAML
on BM subpopulations enriched for LT-HSCs, using additional
criteria (Figures 2D–2F).
Expression of the SLAM molecule CD150 in the absence of
CD48 defines a small population of cells highly enriched for
LT-HSCs (Kiel et al., 2005). We found that 7%–8% of LSK pro-
genitors had a CD150+CD48– phenotype in both control and
DNMAML-expressing BM cells (Figure 2D). Low-level expres-
sion of Thy1.1 in B6-Thy1.1 mice and absence of the cytokine
receptor Flt3 have also been used to define a population highly
enriched in LT-HSCs (Adolfsson et al., 2001; Christensen and
Weissman, 2001). We transduced B6-Thy1.1 BM with MigR1
or DNMAML and reconstituted irradiated recipients (Figure 2E).
At steady state, Flt3–Thy1.1lo cells represented 35% of GFP+
LSK progenitors in both the MigR1 and DNMAML-transduced358 Cell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc.progenitors. Active extrusion of supravital dyes is another
method to enrich for LT-HSCs. For example, dye efflux gener-
ates a characteristic ‘‘side population’’ (SP) appearance when
BM cells stained with Hoechst 33342 are examined for a combi-
nation of blue and red fluorescence. These SP cells harbor the
vast majority of LT-HSCs (Goodell et al., 1996). The frequency
of the SP population was not significantly different between
GFP+ control cells and DNMAML-transduced cells (Figure 2F).
Altogether, these data show that inhibiting canonical Notch
signaling does not affect the overall frequency of BM LSK
progenitors or the frequency of LSK fractions highly enriched
for LT-HSCs.
Secondary Competitive Repopulation Assays
The most sensitive measures of HSC function are assays in
which test progenitors are serially transplanted into irradiated
recipients with normal competitor cells. To assess if Notch inhi-
bition resulted in subtle LT-HSC defects, we performed second-
ary competitive transplants with MigR1 or DNMAML-transduced
LSK cells (Figure 3). BM cells from a CD45.1+ B6 donor were
transduced with MigR1 or DNMAML and used to reconstitute
irradiated CD45.2+ B6 recipients (Figure 3A). Twelve weeks after
this primary transplantation, we purified CD45.1+ GFP+ MigR1 or
DNMAML-transduced LSK cells and transplanted a mixture of
transduced LSK cells (n = 500) and fresh CD45.2+ competitor
BM cells (n = 2 3 105) into irradiated secondary CD45.2+ B6 re-
cipients. We assessed the contribution of donor CD45.1+ GFP+
cells to the myeloid, B, and T cell lineages 16 weeks after trans-
plantation (Figure 3B). There was no difference in the contribu-
tion of control and DNMAML-transduced cells to the myeloid
and B cell lineages at 16 weeks (p = 0.42 and p = 0.26). In con-
trast, DNMAML-transduced cells were absolutely deficient in
T lineage reconstitution (p < 0.001), indicating that the effect of
DNMAML persisted throughout the experiment.
Finally, we assessed LT-HSC function in limiting dilution com-
petitive transplantation assays (Table 1) (Szilvassy et al., 1990).
Decreasing numbers of MigR1 or DNMAML-transduced LSK
cells were transplanted together with normal competitor BM
cells. At 16 weeks after reconstitution, we assessed chimerism
and scored recipient mice for long-term myeloid engraftment
(defined as >1% donor-derived cells). In this assay, we focused
on the myeloid compartment to avoid possible biases caused by
Notch effects on lymphoid commitment. Poisson statistics
showed no significant difference in the frequency of long-term
myeloid repopulation among control and DNMAML-transduced
cells (Table 1), with a nonsignificant trend toward modestly
enhanced activity in Notch-deprived progenitors. Thus, even in
the setting of a limiting dilution assay, inhibition of canonical
Notch signaling did not impair the long-term repopulation activity
of BM progenitors.
Early Hematopoietic Recovery
from Notch-Deprived Progenitors
Next, we assessed if Notch deprivation affected early stages
of hematopoietic recovery. To this end, we transplanted
poly(I:C)-induced Mx-Cre+ 3 ROSADNMAML/+ mice or control
poly(I:C)-treated BM into lethally irradiated recipients, in the
absence of competitor cells. In this setting, recipient mice
showed >95% reconstitution with DNMAML-GFP-expressing
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Notch and Adult Hematopoietic Stem CellsFigure 2. Normal Frequency of Populations Enriched for LT-HSCs in Notch-Deprived BM
(A) Frequency of Lin–/loSca-1hic-Kithi (LSK) progenitors in the control GFP+ fraction of MigR1 BM (n = 7) or in DNMAML-transduced BM (n = 8) 16 weeks after
reconstitution. One representative example is shown.
(B) Frequency of LSK progenitors among GFP– and GFP+ BM cells in mice reconstituted with MigR1 (n = 7) or DNMAML-transduced BM (n = 8). The data are
shown as mean ± two SEM.
(C) Analysis of BM LSK progenitors inMx-Cre– ROSADNMAML/+ orMx-Cre+ ROSADNMAML/+ mice, after induction of Cre expression with poly(I:C). More than 98% of
the cells in the LSK population had achieved DNMAML activation (Figure S1). One representative example is shown (n = 5).
(D) CD150 and CD48 expression in LSK cells of Mx-Cre– ROSADNMAML/+ (n = 6) or Mx-Cre+ ROSADNMAML/+ (n = 4) mice after poly(I:C) induction. One represen-
tative example is shown.
(E) Flt3 and Thy1.1 expression in GFP+ BM LSK cells of mice reconstituted with MigR1 or DNMAML-transduced B6-Thy1.1 BM. One representative example is
shown (n = 5).
(F) Side population (SP) analysis after labeling BM cells with Hoechst 33342 and gating on GFP+ BM. One representative example is shown (n = 5). Numeric data
displayed in the contour plot represent the means ± two SEM.progenitors. Eight weeks after transplantation, mice were
challenged with a single injection of 5-fluorouracil (5-FU) and
assessed with weekly complete blood counts during BM abla-
tion and recovery. We observed no significant difference in the
recovery of white blood cell, platelet, and red cell counts in the
two groups of mice (Figure S3). This similarity extended to
the transient elevation of platelet and white cell counts ob-
served 2–3 weeks after 5-FU challenge. We also did not detect
any defect in blood count recovery at early time points after
transplantation of Mx-Cre+ 3 ROSADNMAML/+ BM into lethally
irradiated recipients or any change in blood chimerism after
5-FU challenge of the CD45.1/CD45.2 Mx-Cre ROSADNMAML/+
mixed chimeras described in Figure 1C (data not shown). Alto-
gether, these findings suggest that canonical Notch signalingis not required for early hematopoietic recovery after BM abla-
tion.
Normal HSC Numbers and Function
in the Absence of CSL/RBPJ
To assess the impact of Notch deprivation by another genetic
approach, we studied mice carrying a conditional Rbpj gene
(Han et al., 2002; Tanigaki et al., 2002, 2004), which encodes
a DNA-binding factor that is essential for signaling from all Notch
receptors. After breeding to Mx-Cre transgenic mice, we in-
duced Cre expression with poly(I:C) and harvested BM cells for
competitive transplantation experiments. Mx-Cre+ Rbpjf/f BM
and control Rbpjf/f BM produced similar levels of stable long-
term chimerism in blood myeloid cells (Figure 4A) and B cellsCell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc. 359
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Notch and Adult Hematopoietic Stem CellsFigure 3. Competitive Repopulation Poten-
tial of Notch-Deprived LSK Progenitors in
Secondary Recipients
(A) Experimental design. MigR1 or DNMAML-
transduced progenitors were used to repopulate
primary lethally irradiated recipients. After 12
weeks, purified GFP+ LSK cells were used in a sec-
ondary transplantation together with host-type
competitor BM cells (500 and 2 3 105 cells, re-
spectively).
(B) Blood of the secondary recipients analyzed 16
weeks after transplantation for donor-derived my-
eloid (Gr1+CD11b+), B (CD19+), and T (Thy1.2+) lin-
eage cells (MigR1 LSK, n = 8; DNMAML LSK, n =
10). There was no significant difference between
the ability of control and DNMAML-transduced
LSK cells to repopulate the myeloid and B cell lin-
eages (p = 0.42 and p = 0.26, respectively, Stu-
dent’s t test). DNMAML LSK cells were deficient
at repopulating the T cell compartment (p < 0.001).(data not shown). When analyzed 18 weeks after transplantation,
as compared to control CD45.2+ cells, we found a similar or even
slightly higher contribution of CSL/RBPJ-deficient cells to the
BM LSK, myeloid, and B lineage progenitor populations (Fig-
ure 4B). In contrast, there was virtually no contribution of
Mx-Cre+ Rbpjf/f CD45.2+ cells to the T cell and MZB cell lineages
(Figure 4B and Figure S4A). This was consistent with efficient
Rbpj inactivation and little or no selection for rare cells that might
have escaped Cre-mediated excision (Figure S4B). Finally, we
assessed the frequency of LSK progenitors, as well as LSK
subsets further enriched for LT-HSCs, in engrafted CD45.2+
BM cells (Figure 4C). There was no significant difference in
LSK or LT-HSC frequency in control and CSL/RBPJ-deficient
BM cell populations. These results were consistent with our
observations using the DNMAML system and reinforce our
conclusion that canonical Notch signaling has no physiologic
role in the maintenance of adult BM HSCs.
Low Abundance of Notch Target Gene Transcripts
in Primitive BM Progenitors
Whereas induction of Notch signaling can enhance the self-
renewal of primitive hematopoietic progenitors, inhibition of
endogenous Notch signals with DNMAML did not impair HSC360 Cell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc.numbers or function, suggesting that under basal physiologic
conditions there might be little ongoing Notch signaling in
HSCs. Thus, we studied the expression of Notch-regulated
genes in HSCs and other progenitors (Figure 5). Transcript levels
were compared between BM LSK cells and populations of T cell
progenitors that experience high (ETP, early T lineage progeni-
tors; DN3, CD44–CD25+ CD4–CD8– double-negative thymo-
cytes) or low levels of Notch signaling (DP, CD4+CD8+ double-
positive thymocytes) (Figure 5A). The amount of Hes1 mRNA in
LSK progenitors was low, similar to the amount found in DP
thymocytes, and 10- to 20-fold lower than in ETP and DN3
cells. We then studied the expression of Dtx1, a gene whose ex-
pression correlates with Notch signaling intensity (Deftos et al.,
2000; Saito et al., 2003; Sambandam et al., 2005; Maillard
et al., 2006a).Dtx1mRNA was undetectable in LSK cells, present
at low levels in DP thymocytes, and markedly upregulated in ETP
and DN3 cells. Critical components of the Notch signaling path-
way were expressed in LSK cells, as noted previously (Milner
et al., 1994; Calvi et al., 2003; Maillard et al., 2006a). Specifically,
Notch1, Notch2, and Maml1 mRNAs were readily detected
(Figure 5A), as wereMaml2 andMaml3mRNAs (data not shown).
Therefore, LSK progenitors express core components of Notch
signaling but low levels of Notch target gene mRNA.Table 1. Long-Term Myeloid Repopulation Potential of Control (MigR1-Transduced) and Notch-Deprived (DNMAML-Transduced) LSK
Progenitors
LSK Number
MigR1 GFP+ LSK Positive for Donor
Engraftment/Total Mice
DNMAML GFP+ LSK Positive For Donor
Engraftment/Total Mice
500 7/8 10/10
150 5/9 7/9
50 3/7 5/10
Reconstitution frequency
(95% confidence interval)
1:182 (1:100–1:332) 1:86 (1:48–1:154)
Cohorts of lethally irradiated recipient mice were transplanted with decreasing numbers of GFP+ MigR1 or DNMAML-transduced LSK cells (500, 150,
50), together with a fixed dose of host-type BM (2 3 105). Blood was analyzed 16 weeks after reconstitution for the percentage of donor-derived
myeloid cells. Positive engraftment was defined as >1% donor-derived cells. Poisson statistics were used to calculate the frequency of long-term
repopulation units. Data from the cohort of mice receiving 500 LSK cells are also included in Figure 3.
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Notch and Adult Hematopoietic Stem CellsFigure 4. LT-HSC Numbers and Function in the Absence of CSL/RBPJ
(A) Stable CD45.2+ chimerism in lethally irradiated recipients of BM cells from poly(I:C)-treated Mx-Cre+ Rbpjf/f (black triangles) or control Rbpjf/f CD45.2+ mice
(white triangles) (n = 5 in each group). Chimerism was assessed by analysis of blood Gr1+CD11b+ myeloid cells. Data are the means ± SEM.
(B) Mixed BM recipients analyzed 18 weeks after BMT for the contribution of CD45.2+ cells to BM LSK progenitors (Lin–/loSca-1hic-Kithi), myeloid cells
(Gr1+CD11b+), pro- and pre-B cells (B220+BP-1+sIgM–), double-positive (DP) thymocytes (CD4+CD8+), and spleen MZB cells (B220+CD21hiCD23lo). Data are
means ± SEMs (n = 5 in each group). Double asterisk (**) indicates statistical significance (Student’s t test, p < 0.01).
(C) Similar frequency of LSK progenitors and CD34–Flt3– LSK cells (enriched for LT-HSC) in engrafted control and CSL/RBPJ-deficient BM 18 weeks after com-
petitive transplantation. Plots show a representative example; bar graphs indicate means ± SDs.We next asked whether the expression of Notch target genes
in LSK cells might result from low but detectable levels of canon-
ical Notch signaling by determining if gene expression was
affected by DNMAML (Figure 5B). Hes1 transcript levels were
not different in control and DNMAML-transduced LSK progeni-
tors, whereas Dtx1 transcripts were undetectable in both.
We also measured c-myc mRNA, because c-myc is regulated
by Notch signaling in certain contexts and plays a role in HSC ho-
meostasis (Wilson et al., 2004; Klinakis et al., 2006; Palomero
et al., 2006; Sharma et al., 2006; Weng et al., 2006). The
abundance of c-myc transcripts was similar in control and
DNMAML-transduced LSK cells. Finally, we assessed Runx1
mRNA, because Notch signaling has been reported to upregu-
late Runx1 in zebrafish hematopoietic progenitors (Burns et al.,2005). DNMAML expression did not affect Runx1 expression in
LSK progenitors. Therefore, regulatory inputs other than canon-
ical Notch signaling must contribute to basal levels of Hes1,
c-myc, and Runx1 expression in adult mouse hematopoietic
progenitors. Altogether, these data suggest that LSK progenitors
have low levels of Notch signaling under basal conditions in vivo.
Rapid Inducibility of Notch Signaling
in Primitive BM Progenitors
Next, we asked if Notch signaling could be induced by exposure
of LSK cells to Notch ligands ex vivo (Figure 6). We cultured con-
trol or DNMAML LSK cells with OP9-DL1 stromal cells express-
ing the Notch ligand Delta-like-1 (Schmitt and Zuniga-Pflucker,
2002) or control OP9 cells. Six hours of coculture with OP9-DL1Cell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc. 361
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Notch and Adult Hematopoietic Stem CellsFigure 5. LSK Progenitors Are Physiologically Exposed to a Low Intensity of Notch Signaling
(A) LSK progenitors were assessed by real-time RT-PCR in comparison to early T lineage progenitors (ETP), DN3, and CD4+CD8+ DP thymocytes. The amount of
the Notch target gene transcripts Hes1 and Dtx1 (normalized to Hprt) was very low in LSK cells and DP thymocytes but high in ETP and DN3 cells. Results are
given as the mean ± SEM. ND, not detectable.
(B)Hes1,Dtx1, c-myc Notch1,Notch2, andRunx1 transcripts in control and DNMAML-expressing LSK progenitors (normalized toHprt). The measurements were
performed in triplicates for four to five independent samples. Results are given as the mean ± SEM. ND, not detectable.was sufficient to induce Dtx1 mRNA (Figure 6A). This upre-
gulation was abolished in DNMAML-expressing LSK cells.
When the coculture was continued for 48 hr (Figure 6B), expo-
sure to OP9-DL1 resulted in both Hes1 and Dtx1 upregulation,
and this again was completely inhibited by DNMAML. Other in-
vestigators have reported that the rapid upregulation of Hes1
and Dtx1 mRNA in cocultures of progenitors with OP9-DL1 cells
occurs before induction of T lineage specification (Taghon et al.,
2005). Our findings confirm that DNMAML efficiently blocks
Notch signaling in the context of primitive hematopoietic progen-
itors and show that, although LSK progenitors are poised to
transduce Notch signals, they do so at only low levels within their
physiological niche in vivo.
DISCUSSION
The homeostasis of tissue stem cells is a carefully regulated
process that balances long-term self-renewal and differentiation362 Cell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc.into downstream progeny. Like other kinds of tissue stem cells,
HSCs are maintained in a stem cell niche, a specialized microen-
vironment that provides critical signals to support HSC activity
(Moore and Lemischka, 2006; Scadden, 2006; Wilson and
Trumpp, 2006). Along with other pathways, Notch signaling
induced by ligands expressed on support cells in the niche has
been hypothesized to contribute to HSC homeostasis. This
hypothesis is based on the ability of Notch signals to regulate
progenitor self-renewal and differentiation in certain contexts
and observations showing that experimentally enhanced Notch
signals increase the self-renewal of hematopoietic progenitors
in vitro and in vivo. In contrast, the importance of endogenous
Notch signaling in HSCs under physiologic conditions has
been unclear and controversial. Here, we addressed this ques-
tion by interfering with Notch-mediated transcriptional activation
using DNMAML, a potent and specific pan-inhibitor of Notch
signaling, and through disruption of the Rbpj gene. This is the
first report, to the best of our knowledge, describing stringentFigure 6. DNMAML Inhibits the Rapid In-
duction of Notch Signaling after Exposure
of LSKProgenitors toNotch Ligands In Vitro
Freshly purified LSK progenitors from control or
DNMAML-expressing BM were cultured with stro-
mal monolayers of OP9 cells or OP9-DL1 cells ex-
pressing the Notch ligand Delta-like1. The amount
of Hes1 and Dtx1 mRNA (normalized to Hprt) was
assessed by real-time RT-PCR in LSK progenitors
after 6 (A) or 48 hr (B) of coculture. The data are the
means ± SEM. ND, not detectable.
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Notch and Adult Hematopoietic Stem Cellsin vivo assays of LT-HSC activity in the absence of canonical
Notch signals from all four mammalian Notch receptors. Our ob-
servations rule out a significant effect of cell-autonomous canon-
ical Notch signals on LT-HSC maintenance in vivo. In addition,
they indicate that primitive hematopoietic progenitors in the
BM are exposed to low levels of Notch signaling under basal
physiologic conditions.
Our findings are based on an examination of HSC function in
the normal mouse BM environment as well as upon serial HSC
transplantation in radiation chimeras. Our results clearly show
that, in these situations, canonical Notch signaling is not a signif-
icant regulator of HSC self-renewal. However, our observations
leave open the possibility that Notch might play a role in HSC
function if Notch ligand expression is induced in the BM micro-
environment. For example, parathyroid hormone (PTH) regulates
HSC self-renewal though the activation of osteoblasts, a phe-
nomenon that correlates with increased expression of the Notch
ligand Jagged1 (Calvi et al., 2003). It is conceivable that, upon
Jagged1 upregulation, HSCs might be exposed to elevated
levels of Notch signaling in the osteoblastic stem cell niche.
This is consistent with the finding that inhibition of Notch signal-
ing in cocultures of HSC and PTH-treated stroma abolishes the
incremental effect of PTH on HSC self-renewal but does not
influence basal HSC activity (Calvi et al., 2003). In future work,
it will be important to evaluate if Notch signaling is a relevant reg-
ulator of HSC homeostasis in situations of hematopoietic stress
other than radiation, such as inflammatory states, as well as in
primary hematopoietic disorders.
DNMAML is a highly specific inhibitor of canonical Notch sig-
naling through the CSL/RBPJ-ICN-MAML complex. Our studies
demonstrate that this canonical pathway has no detectable role
in HSC self-renewal but do not rule out Notch effects mediated
through noncanonical pathways. Noncanonical pathways have
been proposed based on genetic observations in flies that sug-
gest the existence of CSL/RBPJ-independent Notch pheno-
types (Martinez Arias et al., 2002) and results obtained with
cultured mammalian cells (Shawber et al., 1996; Nofziger et al.,
1999). At present, the biochemical details of the noncanonical
pathways remain unknown. Importantly, all phenotypes pro-
duced to date through genetic deficiencies of individual Notch
receptors in mice have been phenocopied by Rbpj deletion or
DNMAML expression, indicating that they are due to defects in
canonical Notch signaling.
The low abundance of Notch target gene transcripts in hema-
topoietic progenitors suggests that HSCs experience minimal
to no Notch signaling in vivo. Because Notch signaling was rap-
idly induced after short-term exposure of LSK progenitors to
Notch ligands ex vivo, it appears paradoxical that these cells
fail to respond to Notch ligands expressed in the BM microenvi-
ronment. However, the concentration of Notch ligands might be
insufficient to induce significant levels of Notch signaling in the
HSC niche in vivo. Another nonmutually exclusive possibility is
that LSK progenitors use intrinsic mechanisms to downregulate
their responsiveness to Notch ligands, so that they only respond
when exposed to high concentrations of ligands or to specific
Notch ligand families (such as Delta-like ligands). For example,
Fringe glycosylases could specifically downregulate the respon-
siveness of Notch receptors to Jagged in the BM HSC niche
(Visan et al., 2006). Another intrinsic factor that negatively influ-ences Notch signaling in the HSC compartment is LRF/Poke-
mon, loss of which leads to cell-autonomous derepression of
Notch signaling in BM LSK progenitors (Maeda et al., 2007).
Such putative mechanisms likely serve to prevent ectopic
Notch-mediated commitment to the T cell lineage and suppres-
sion of B cell development in the BM.
Our findings indicate that low-level expression of certain
Notch target genes, such as Hes1, can occur independently of
canonical Notch signals. Thus, studies using Hes1 expression
as a sole indicator of ongoing Notch signaling should be inter-
preted with caution (Harman et al., 2005; Yu et al., 2006). Indeed,
E2A transcription factors can upregulate Hes1 expression inde-
pendently of Notch (Ikawa et al., 2006), and these and other fac-
tors could account for the Notch-independent expression of
Hes1 in BM LSK progenitors. Furthermore, modulation of Hes1
expression might be relevant to HSC function independently of
Notch, because Hes1 overexpression increases LT-HSC self-
renewal (Kunisato et al., 2003; Yu et al., 2006).
Our conclusions differ from those of Reya and coworkers, who
postulated an essential role for canonical Notch signals down-
stream of Wnt in HSC homeostasis (Duncan et al., 2005). Using
a transgenic GFP reporter based on multimerized CSL/RBPJ
binding sites, Duncan et al. described that a high proportion of
BM LSK progenitors expressed GFP, suggesting that they
were exposed to Notch signals in vivo. In fact, the percentage
of GFP+ LSK cells in the BM was in the same range as the
percentage of GFP+ cells among DN thymocytes, which experi-
ence high levels of Notch activation. This is in direct contrast to
our findings, which showed that Notch target gene transcripts
were present at much lower levels in BM LSK cells than in DN
thymocytes. It is possible that the transgenic reporter gene
used by these investigators was expressed in a Notch-indepen-
dent fashion in BM LSK cells. Duncan et al. also reported defec-
tive LT-HSC competitive repopulation of LSK cells transduced
in vitro with dnXSu(H) (a dominant-negative inhibitor of the
Xenopus CSL/RBPJ homolog), a finding that differs from our ob-
servations with DNMAML-expressing and CSL/RBPJ-deficient
cells. Unlike DNMAML, whose in vivo effects correlate with
Notch loss-of-function phenotypes, the in vivo activity of
dnXSu(H) has not been fully described. In any case, the normal
self-renewal of DNMAML-expressing and CSL/RBPJ-deficient
LT-HSCs, two conditions that completely inhibit Notch signaling,
definitively shows that canonical Notch signaling is not required
for LT-HSC maintenance in vivo.
Combinations of gain and loss-of-function approaches have
provided important insights into the effects of Notch in different
contexts. For example, inhibition of Notch signaling leads to de-
fective T cell development and abnormal B cell expansion in the
thymus, whereas induction of Notch signals at supraphysiologi-
cal levels results in T cell development and suppression of B cell
development at extrathymic sites (Pui et al., 1999; Radtke et al.,
1999). Such symmetrical phenotypes in cell-fate decisions are
expected if the intensity of Notch signaling is high enough to sup-
port a physiological effect. In adult HSCs, the intensity of Notch
signaling appears too low to translate into a detectable physio-
logical function. We speculate that avoiding high levels of Notch
signaling in primitive hematopoietic progenitors is a carefully
regulated phenomenon that has an important physiological
role, perhaps to prevent ectopic development of T cells andCell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc. 363
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may be important to actively suppress Notch signals in HSCs,
as these cells may otherwise be exposed to high-intensity Notch
signaling as a consequence of the requirement for the Notch
pathway to maintain other elements of the BM microenvironment
(Engin et al., 2008; Hilton et al., 2008).
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6, CD45.2+) were from Taconic (Germantown, NY). C57BL/6.Ly5.2
(B6-SJL, CD45.1+) were from the NCI (Frederick, MD) or bred locally (EPFL–
ISREC, Switzerland). C57BL/6-Thy1a (B6-Thy1.1, Thy1.1+) were from Jack-
son Laboratories (Bar Harbor, ME). ROSADNMAML/+ mice were generated as
described (Tu et al., 2005; Maillard et al., 2006b) and crossed to Mx-Cre
transgenic mice (Jackson Laboratories). The Mx-Cre transgene was also
bred to the Rbpjf/f background (Han et al., 2002; Tanigaki et al., 2002). Cre
expression was induced with poly(I:C) (Sigma, St. Louis, MO) (500 mg i.p.
every 2 days for 10 days, repeated once). DNMAML induction was monitored
through GFP expression in blood Gr1+CD11b+ cells (routinely >95%). The
efficiency of Rbpj excision was assessed by Southern blotting, as described
in the Supplemental Experimental Procedures. Experimental protocols were
approved by the University of Pennsylvania’s Office of Regulatory Affairs
and by the veterinary authorities of the Canton de Vaud, Switzerland
(authorization 1099.3).
Constructs and Retroviruses
The GFP-expressing MigR1 and the dominant-negative DNMAML-GFP MSCV
constructs (DNMAML) have been described previously (Weng et al., 2003;
Maillard et al., 2004). High-titer retroviral supernatant was produced by tran-
sient transfection of 293T cells (Pui et al., 1999).
Flow Cytometry and Cell Sorting
A list of antibodies is provided in the Supplemental Experimental Procedures.
Cells were sorted with a FACSAria (Becton Dickinson) or MoFlo (Cytomation,
Fort Collins, CO). Analysis was performed on FACSCanto, LSR II (Becton
Dickinson), or CyAn (Dako). Files were analyzed in FlowJo (Tree Star, San
Carlos, CA). SP analysis was performed on an LSR II equipped with an
ultraviolet laser, after incubation with Hoechst 33342 (Sigma), as described
(Goodell et al., 1996).
BM Transduction and Transplantation
Retroviral transduction of 5-FU-treated BM cells and transplantation into irra-
diated (900 rads) recipients was performed as described (Pui et al., 1999).
Competitive HSC Transplantation
CD45.2+ BM from poly(I:C)-induced Mx-Cre+3 ROSADNMAML/+ or control Mx-
Cre– littermates was mixed at a 1:1 ratio with competitor B6-SJL CD45.1+ BM
(106 cells each) and transplanted into lethally irradiated B6-SJL recipients (900
rads). For experiments involving Rbpjf/f mice, donor BM was T cell depleted
prior to transplantation by using an anti-Thy1.2 (AT83) monoclonal antibody
and rabbit complement (Saxon, UK). Mixed BM chimeras were prepared
with irradiated B6-SJL recipients (1000 rads) treated 48 hr previously with
100 mg anti-NK1.1 monoclonal antibodies i.p. B6-SJL recipients were recon-
stituted with a 1:1 mixture (3 3 106 cells each) of poly(I:C)-induced B6-SJL
CD45.1+ BM and either poly(I:C)-induced CD45.2+ Mx-Cre+ RBPJf/f or control
MxCre BM. For secondary transplantation, BM GFP+ LSK cells were purified
from recipients of MigR1 or DNMAML-transduced B6-SJL (CD45.1+) BM
at least 12 weeks after transplantation. Sorted LSK cells (500) were trans-
planted into lethally irradiated B6 recipients together with 2 3 105 competitor
B6 BM cells (CD45.2+). In limiting dilution analyses, decreasing numbers of
tester LSK cells were used (500, 150, 50). Blood was analyzed 16 weeks after
secondary transplantation. Engraftment was defined as >1% tester cells in
Gr1+CD11b+ blood myeloid cells. The progenitor frequency was calculated
with L-Calc software (StemCell Technologies).364 Cell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc.OP9 Cultures
OP9-MigR1 (OP9) and OP9-DL1 cells were kindly provided by J.C. Zuniga-
Pflucker (University of Toronto, Canada) and used as described (Schmitt
and Zuniga-Pflucker, 2002). LSK progenitors (104) were seeded into 24-well
plates containing a confluent stromal monolayer in the presence of mSCF
(100 ng/ml), hFlt3L (5 ng/ml), and mIL-7 (1 ng/ml) (Peprotech, Rocky Hill,
NJ). After 6–48 hr, progenitors were isolated on the basis of CD45 expression.
Quantitative RT-PCR
RNA was purified with the RNEasy Micro Kit (QIAGEN, Valencia, CA). cDNA
was prepared with the Superscript II Kit (Invitrogen, Carlsbad, CA). Real-
time PCR was performed with SYBRGreen or TaqMan PCR Master Mix and
analyzed on ABI Prism 7900 system (Applied Biosystems, Foster City, CA).
Primers and probes are listed in the Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and four
figures and can be found with this article online at http://www.cellstemcell.
com/cgi/content/full/2/4/356/DC1/.
ACKNOWLEDGMENTS
This work was supported by grants from the NIH (J.C.A., A.B., and W.S.P.), an
LLS SCOR grant to W.S.P. and J.C.A., an LLS Scholar Award to A.B., and by
the Swiss National Science Foundation (U.K., A.D., and F.R.). I.M. was sup-
ported by the Damon Runyon Cancer Research Foundation (DRG-102-05).
We thank Prof. S. Morrison for critically reading the manuscript and Prof. T.
Honjo for providing conditional Rbpj knockout mice.
Received: March 30, 2007
Revised: January 14, 2008
Accepted: February 14, 2008
Published: April 9, 2008
REFERENCES
Adolfsson, J., Borge, O.J., Bryder, D., Theilgaard-Monch, K., Astrand-Grund-
strom, I., Sitnicka, E., Sasaki, Y., and Jacobsen, S.E. (2001). Upregulation of
Flt3 expression within the bone marrow Lin(-)Sca1(+)c- kit(+) stem cell com-
partment is accompanied by loss of self-renewal capacity. Immunity 15,
659–669.
Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. (1999). Notch signaling:
cell fate control and signal integration in development. Science 284, 770–776.
Burns, C.E., Traver, D., Mayhall, E., Shepard, J.L., and Zon, L.I. (2005). Hema-
topoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev.
19, 2331–2342.
Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight,
M.C., Martin, R.P., Schipani, E., Divieti, P., Bringhurst, F.R., et al. (2003).
Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 425,
841–846.
Carlesso, N., Aster, J.C., Sklar, J., and Scadden, D.T. (1999). Notch1-induced
delay of human hematopoietic progenitor cell differentiation is associated with
altered cell cycle kinetics. Blood 93, 838–848.
Chiba, S. (2006). Notch signaling in stem cell systems. Stem Cells 24, 2437–
2447.
Christensen, J.L., and Weissman, I.L. (2001). Flk-2 is a marker in hematopoi-
etic stem cell differentiation: a simple method to isolate long-term stem cells.
Proc. Natl. Acad. Sci. USA 98, 14541–14546.
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm,
J.S., Schroeter, E.H., Schruvers, V., Wolfe, M.S., Ray, W.J., et al. (1999). A pre-
senilin-1-dependent -secretase-like protease mediates release of Notch intra-
cellular domain. Nature 398, 518–522.
Deftos, M.L., Huang, E., Ojala, E.W., Forbush, K.A., and Bevan, M.J. (2000).
Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes.
Immunity 13, 73–84.
Cell Stem Cell
Notch and Adult Hematopoietic Stem CellsDuncan, A.W., Rattis, F.M., DiMascio, L.N., Congdon, K.L., Pazianos, G.,
Zhao, C., Yoon, K., Cook, J.M., Willert, K., Gaiano, N., et al. (2005). Integration
of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Im-
munol. 6, 314–322.
Engin, F., Yao, Z., Yang, T., Zhou, G., Bertin, T., Jiang, M.M., Chen, Y., Wang,
L., Zheng, H., Sutton, R.E., et al. (2008). Dimorphic effects of Notch signaling in
bone homeostasis. Nat. Med. 14, 299–305.
Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. (1996).
Isolation and functional properties of murine hematopoietic stem cells that are
replicating in vivo. J. Exp. Med. 183, 1797–1806.
Hadland, B.K., Huppert, S.S., Kanungo, J., Xue, Y., Jiang, R., Gridley, T.,
Conlon, R.A., Cheng, A.M., Kopan, R., and Longmore, G.D. (2004). A require-
ment for Notch1 distinguishes two phases of definitive hematopoiesis during
development. Blood 104, 3097–3105.
Han, H., Tanigaki, K., Yamamoto, N., Kuroda, K., Yoshimoto, M., Nakahata, T.,
Ikuta, K., and Honjo, T. (2002). Inducible gene knockout of transcription factor
recombination signal binding protein-J reveals its essential role in T versus B
lineage decision. Int. Immunol. 14, 637–645.
Harman, B.C., Jenkinson, W.E., Parnell, S.M., Rossi, S.W., Jenkinson, E.J.,
and Anderson, G. (2005). T/B lineage choice occurs prior to intrathymic notch
signalling. Blood 106, 886–892.
Hilton, M.J., Tu, X., Wu, X., Bai, S., Zhao, H., Kobayashi, T., Kronenberg, H.M.,
Teitelbaum, S.L., Ross, F.P., Kopan, R., and Long, F. (2008). Notch signaling
maintains bone marrow mesenchymal progenitors by suppressing osteoblast
differentiation. Nat. Med. 14, 306–314.
Ikawa, T., Kawamoto, H., Goldrath, A.W., and Murre, C. (2006). E proteins and
Notch signaling cooperate to promote T cell lineage specification and commit-
ment. J. Exp. Med. 203, 1329–1342.
Jarriault, S., Brou, C., Logeat, F., Schroeter, E.H., Kopan, R., and Israel, A.
(1995). Signalling downstream of activated mammalian Notch. Nature 377,
355–358.
Jeffries, S., Robbins, D.J., and Capobianco, A.J. (2002). Characterization of
a high-molecular-weight notch complex in the nucleus of Notch(ic)-trans-
formed RKE cells and in a human T-cell leukemia cell line. Mol. Cell. Biol.
22, 3927–3941.
Karanu, F.N., Murdoch, B., Miyabayashi, T., Ohno, M., Koremoto, M.,
Gallacher, L., Wu, D., Itoh, A., Sakano, S., and Bhatia, M. (2001). Human homo-
logues of Delta-1 and Delta-4 function as mitogenic regulators of primitive
human hematopoietic cells. Blood 97, 1960–1967.
Kiel, M.J., Yilmaz, O.H., Iwashita, T., Yilmaz, O.H., Terhorst, C., and Morrison,
S.J. (2005). SLAM family receptors distinguish hematopoietic stem and pro-
genitor cells and reveal endothelial niches for stem cells. Cell 121, 1109–1121.
Klinakis, A., Szabolcs, M., Politi, K., Kiaris, H., Artavanis-Tsakonas, S., and
Efstratiadis, A. (2006). Myc is a Notch1 transcriptional target and a requisite
for Notch1-induced mammary tumorigenesis in mice. Proc. Natl. Acad. Sci.
USA 103, 9262–9267.
Kondo, M., Wagers, A.J., Manz, M.G., Prohaska, S.S., Scherer, D.C., Beilhack,
G.F., Shizuru, J.A., and Weissman, I.L. (2003). Biology of hematopoietic stem
cells and progenitors: implications for clinical application. Annu. Rev. Immunol.
21, 759–806.
Kumano, K., Chiba, S., Kunisato, A., Sata, M., Saito, T., Nakagami-Yamaguchi,
E., Yamaguchi, T., Masuda, S., Shimizu, K., Takahashi, T., et al. (2003). Notch1
but not Notch2 is essential for generating hematopoietic stem cells from endo-
thelial cells. Immunity 18, 699–711.
Kunisato, A., Chiba, S., Nakagami-Yamaguchi, E., Kumano, K., Saito, T.,
Masuda, S., Yamaguchi, T., Osawa, M., Kageyama, R., Nakauchi, H., et al.
(2003). HES-1 preserves purified hematopoietic stem cells ex vivo and accu-
mulates side population cells in vivo. Blood 101, 1777–1783.
Maeda, T., Merghoub, T., Hobbs, R.M., Dong, L., Maeda, M., Zakrzewski, J.,
van den Brink, M.R., Zelent, A., Shigematsu, H., Akashi, K., et al. (2007). Reg-
ulation of B versus T lymphoid lineage fate decision by the proto-oncogene
LRF. Science 316, 860–866.Maillard, I., Weng, A.P., Carpenter, A.C., Rodriguez, C.G., Sai, H., Xu, L.,
Allman, D., Aster, J.C., and Pear, W.S. (2004). Mastermind critically regulates
Notch-mediated lymphoid cell fate decisions. Blood 104, 1696–1702.
Maillard, I., Fang, T., and Pear, W.S. (2005). Regulation of lymphoid develop-
ment, differentiation and function by the Notch pathway. Annu. Rev. Immunol.
23, 945–974.
Maillard, I., Schwarz, B.A., Sambandam, A., Fang, T., Shestova, O., Xu, L.,
Bhandoola, A., and Pear, W.S. (2006a). Notch-dependent T-lineage commit-
ment occurs at extrathymic sites following bone marrow transplantation.
Blood 107, 3511–3519.
Maillard, I., Tu, L., Sambandam, A., Yashiro-Ohtani, Y., Millholland, J.,
Keeshan, K., Shestova, O., Xu, L., Bhandoola, A., and Pear, W.S. (2006b).
The requirement for Notch signaling at the beta-selection checkpoint in vivo
is absolute and independent of the pre-T cell receptor. J. Exp. Med. 203,
2239–2245.
Mancini, S.J., Mantei, N., Dumortier, A., Suter, U., Macdonald, H.R., and
Radtke, F. (2005). Jagged1-dependent Notch signaling is dispensable for he-
matopoietic stem cell self-renewal and differentiation. Blood 105, 2340–2342.
Martinez Arias, A., Zecchini, V., and Brennan, K. (2002). CSL-independent
Notch signalling: a checkpoint in cell fate decisions during development?
Curr. Opin. Genet. Dev. 12, 524–533.
Milner, L.A., Kopan, R., Martin, D.I., and Bernstein, I.D. (1994). A human homo-
logue of the Drosophila developmental gene, Notch, is expressed in CD34+
hematopoietic precursors. Blood 83, 2057–2062.
Moore, K.A., and Lemischka, I.R. (2006). Stem cells and their niches. Science
311, 1880–1885.
Morrison, S.J., and Weissman, I.L. (1994). The long-term repopulating subset
of hematopoietic stem cells is deterministic and isolatable by phenotype.
Immunity 1, 661–673.
Nam, Y., Sliz, P., Song, L., Aster, J.C., and Blacklow, S.C. (2006). Structural
basis for cooperativity in recruitment of MAML coactivators to Notch transcrip-
tion complexes. Cell 124, 973–983.
Nofziger, D., Miyamoto, A., Lyons, K.M., and Weinmaster, G. (1999). Notch
signaling imposes two distinct blocks in the differentiation of C2C12 myo-
blasts. Development 126, 1689–1702.
Palomero, T., Lim, W.K., Odom, D.T., Sulis, M.L., Real, P.J., Margolin, A.,
Barnes, K.C., O’Neil, J., Neuberg, D., Weng, A.P., et al. (2006). NOTCH1
directly regulates c-MYC and activates a feed-forward-loop transcriptional
network promoting leukemic cell growth. Proc. Natl. Acad. Sci. USA 103,
18261–18266.
Pui, J.C., Allman, D., Xu, L., DeRocco, S., Karnell, F.G., Bakkour, S., Lee, J.Y.,
Kadesch, T., Hardy, R.R., Aster, J.C., et al. (1999). Notch1 expression in early
lymphopoiesis influences B versus T lineage determination. Immunity 11, 299–
308.
Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., MacDonald, H.R.,
and Aguet, M. (1999). Deficient T cell fate specification in mice with an induced
inactivation of Notch1. Immunity 10, 547–558.
Radtke, F., Wilson, A., Mancini, S.J., and MacDonald, H.R. (2004). Notch reg-
ulation of lymphocyte development and function. Nat. Immunol. 5, 247–253.
Saito, T., Chiba, S., Ichikawa, M., Kunisato, A., Asai, T., Shimizu, K., Yamaguchi,
T., Yamamoto, G., Seo, S., Kumano, K., et al. (2003). Notch2 is preferentially
expressed in mature B cells and indispensable for marginal zone B lineage
development. Immunity 18, 675–685.
Sambandam, A., Maillard, I., Zediak, V.P., Xu, L., Gerstein, R., Aster, J., Pear,
W.S., and Bhandoola, A. (2005). Notch signaling controls the generation and
differentiation of early T lineage progenitors. Nat. Immunol. 6, 663–670.
Scadden, D.T. (2006). The stem-cell niche as an entity of action. Nature 441,
1075–1079.
Schmitt, T.M., and Zuniga-Pflucker, J.C. (2002). Induction of T cell develop-
ment from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity
17, 749–756.
Sharma, V.M., Calvo, J.A., Draheim, K.M., Cunningham, L.A., Hermance, N.,
Beverly, L., Krishnamoorthy, V., Bhasin, M., Capobianco, A.J., and Kelliher,Cell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc. 365
Cell Stem Cell
Notch and Adult Hematopoietic Stem CellsM.A. (2006). Notch1 contributes to mouse T-cell leukemia by directly inducing
the expression of c-myc. Mol. Cell. Biol. 26, 8022–8031.
Shawber, C., Nofziger, D., Hsieh, J.J., Lindsell, C., Bogler, O., Hayward, D.,
and Weinmaster, G. (1996). Notch signaling inhibits muscle cell differentiation
through a CBF1-independent pathway. Development 122, 3765–3773.
Stier, S., Cheng, T., Dombkowski, D., Carlesso, N., and Scadden, D.T. (2002).
Notch1 activation increases hematopoietic stem cell self-renewal in vivo and
favors lymphoid over myeloid lineage outcome. Blood 99, 2369–2378.
Suzuki, T., Yokoyama, Y., Kumano, K., Takanashi, M., Kozuma, S., Takato, T.,
Nakahata, T., Nishikawa, M., Sakano, S., Kurokawa, M., et al. (2006). Highly
efficient ex vivo expansion of human hematopoietic stem cells using Delta1-
Fc chimeric protein. Stem Cells 24, 2456–2465.
Szilvassy, S.J., Humphries, R.K., Lansdorp, P.M., Eaves, A.C., and Eaves, C.J.
(1990). Quantitative assay for totipotent reconstituting hematopoietic stem
cells by a competitive repopulation strategy. Proc. Natl. Acad. Sci. USA 87,
8736–8740.
Taghon, T., David, E.S., Zuniga-Pflucker, J.C., and Rothenberg, E.V. (2005).
Delayed, asynchronous, and reversible T-lineage specification induced by
Notch/Delta signaling. Genes Dev. 19, 965–978.
Tamura, K., Taniguchi, Y., Minoguchi, S., Sakai, T., Tun, T., Furukawa, T., and
Honjo, T. (1995). Physical interaction between a novel domain of the receptor
Notch and the transcription factor RBP-J kappa/Su(H). Curr. Biol. 5, 1416–
1423.
Tanigaki, K., Han, H., Yamamoto, N., Tashiro, K., Ikegawa, M., Kuroda, K.,
Suzuki, A., Nakano, T., and Honjo, T. (2002). Notch-RBP-J signaling is involved
in cell fate determination of marginal zone B cells. Nat. Immunol. 3, 443–450.
Tanigaki, K., Tsuji, M., Yamamoto, N., Han, H., Tsukada, J., Inoue, H., Kubo,
M., and Honjo, T. (2004). Regulation of alphabeta/gammadelta T cell lineage
commitment and peripheral T cell responses by Notch/RBP-J signaling.
Immunity 20, 611–622.
Tu, L., Fang, T.C., Artis, D., Shestova, O., Pross, S.E., Maillard, I., and Pear,
W.S. (2005). Notch signaling is an important regulator of type 2 immunity.
J. Exp. Med. 202, 1037–1042.
Varnum-Finney, B., Purton, L.E., Yu, M., Brashem-Stein, C., Flowers, D.,
Staats, S., Moore, K.A., Le Roux, I., Mann, R., Gray, G., et al. (1998). The Notch
ligand, Jagged-1, influences the development of primitive hematopoietic
precursor cells. Blood 91, 4084–4091.366 Cell Stem Cell 2, 356–366, April 2008 ª2008 Elsevier Inc.Varnum-Finney, B., Xu, L., Brashem-Stein, C., Nourigat, C., Flowers, D.,
Bakkour, S., Pear, W.S., and Bernstein, I.D. (2000). Pluripotent, cytokine-de-
pendent, hematopoietic stem cells are immortalized by constitutive notch1
signaling. Nat. Med. 6, 1278–1281.
Varnum-Finney, B., Brashem-Stein, C., and Bernstein, I.D. (2003). Combined
effects of Notch signaling and cytokines induce a multiple log increase in
precursors with lymphoid and myeloid reconstituting ability. Blood 101,
1784–1789.
Visan, I., Yuan, J.S., Tan, J.B., Cretegny, K., and Guidos, C.J. (2006). Regula-
tion of intrathymic T-cell development by Lunatic Fringe- Notch1 interactions.
Immunol. Rev. 209, 76–94.
Weng, A.P., Nam, Y., Wolfe, M.S., Pear, W.S., Griffin, J.D., Blacklow, S.C., and
Aster, J.C. (2003). Growth suppression of pre-T acute lymphoblastic leukemia
cells by inhibition of notch signaling. Mol. Cell. Biol. 23, 655–664.
Weng, A.P., Millholland, J.M., Yashiro-Ohtani, Y., Arcangeli, M.L., Lau, A., Wai,
C., Del Bianco, C., Rodriguez, C.G., Sai, H., Tobias, J., et al. (2006). c-Myc is an
important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lym-
phoma. Genes Dev. 20, 2096–2109.
Wilson, A., and Trumpp, A. (2006). Bone-marrow haematopoietic-stem-cell
niches. Nat. Rev. Immunol. 6, 93–106.
Wilson, J.J., and Kovall, R.A. (2006). Crystal structure of the CSL-Notch-Mas-
termind ternary complex bound to DNA. Cell 124, 985–996.
Wilson, A., Murphy, M.J., Oskarsson, T., Kaloulis, K., Bettess, M.D., Oser,
G.M., Pasche, A.C., Knabenhans, C., Macdonald, H.R., and Trumpp, A.
(2004). c-Myc controls the balance between hematopoietic stem cell self-
renewal and differentiation. Genes Dev. 18, 2747–2763.
Wu, L., Aster, J.C., Blacklow, S.C., Lake, R., Artavanis-Tsakonas, S., and
Griffin, J.D. (2000). MAML1, a human homologue of drosophila mastermind,
is a transcriptional co-activator for NOTCH receptors. Nat. Genet. 26, 484–
489.
Wu, L., Sun, T., Kobayashi, K., Gao, P., and Griffin, J.D. (2002). Identification of
a family of mastermind-like transcriptional coactivators for mammalian notch
receptors. Mol. Cell. Biol. 22, 7688–7700.
Yu, X., Alder, J.K., Chun, J.H., Friedman, A.D., Heimfeld, S., Cheng, L., and
Civin, C.I. (2006). HES1 inhibits cycling of hematopoietic progenitor cells via
DNA binding. Stem Cells 24, 876–888.
